<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">



External stories on biodesix

CAP Today: Revived Hopes, Fresh Challenges with Liquid Biopsy

Article in CAP Today about liquid biopsy and the opportunity that tests like Biodesix's Genestrat offer to lung cancer treatment

The Pathologist: Battling Lung Cancer in the Tobacco Belt

Dr. Paul Walker describes how liquid biopsy testing helps battling lung cancer in the tobacco belt. The advantages of liquid biopsy for lung cancer.

Adoption of Liquid Biopsy Tests for NSCLC

Availability of biomarker data early in the treatment process enables tumor boards to review cases more efficiently and to better understand treatment options.

The Future Is Fluid

'Liquid biopsy really opens the possibility of a kind of real-time molecular analysis of the tumor to help inform treatment choices,' Dr. Burstein concluded.

Clinical Lab Products: ROS1/RET Now Available in Liquid Biopsy Test

ROS1 and RET mutations are now available in Biodesix's liquid biopsy test, GeneStrat

CGTV: Biodesix, Bioyong, and Lung Cancer Testing in China—Watch the Video

CGTV (China Television) story on Biodesix's agreement with Bioyong, and why lung cancer tests are needed in China

Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy

“VeriStrat appears to be a robust assay and should be used for EGFR wild-type patients with squamous cell lung cancer,” says study author Glenwood D. Goss, MD, professor of medicine and an oncologist

Biodesix Wins IQ Award for Innovative Company of the Year

Biodesix wins IQ Award for Innovative Company of the Year

"When Lung Cancer Is Diagnosed, Fast Blood Tests Can Help Save Lives"

Researchers suggest in a new study that administering blood tests to lung cancer patients at the time of diagnosis may be able to hasten treatment decisions

GenomeWeb: Biodesix Receives Two Positive Coverage Decisions for Veristrat

GenomeWeb story: Biodesix receives two positive coverage decisions for VeriStrat